Search Results
Department of Hematology, University of Groningen, University Medical Center Groningen, The Netherlands
Search for other papers by Hanneke J C M Wouters in
Google Scholar
PubMed
Search for other papers by Bruce H R Wolffenbuttel in
Google Scholar
PubMed
Search for other papers by Anneke C Muller Kobold in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Gerwin Huls in
Google Scholar
PubMed
Search for other papers by Melanie M van der Klauw in
Google Scholar
PubMed
guidelines. In general, treatment is aimed at abolishing complaints related to hypothyroidism, and normalizing plasma thyroid stimulating hormone (TSH) levels ( 1 ). However, it has been shown that health-related quality of life (HRQoL) improves after 6
Search for other papers by Elizabeth J de Koster in
Google Scholar
PubMed
Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Division of Clinical Studies, Institute of Cancer Research, London, UK
Search for other papers by Olga Husson in
Google Scholar
PubMed
Search for other papers by Eveline W C M van Dam in
Google Scholar
PubMed
Search for other papers by G Sophie Mijnhout in
Google Scholar
PubMed
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands
Department of Biomedical Sciences and Humanitas Clinical and Research Centre, Department of Nuclear Medicine, Humanitas University, Milan, Italy
Search for other papers by Wim J G Oyen in
Google Scholar
PubMed
Search for other papers by Marieke Snel in
Google Scholar
PubMed
Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands
Biomedical Photonic Imaging Group, University of Twente, Enschede, The Netherlands
Search for other papers by Lioe-Fee de Geus-Oei in
Google Scholar
PubMed
Search for other papers by Dennis Vriens in
Google Scholar
PubMed
Search for other papers by for the EfFECTS trial study group in
Google Scholar
PubMed
-effective in a Dutch setting, with lower societal lifelong costs while maintaining the long-term health-related quality of life (HRQoL) in patients undergoing FDG-PET/CT-driven management as compared to routine diagnostic surgery or molecular testing ( 8 , 9
Search for other papers by Eeva M Ryhänen in
Google Scholar
PubMed
Search for other papers by Ilkka Heiskanen in
Google Scholar
PubMed
Search for other papers by Harri Sintonen in
Google Scholar
PubMed
Search for other papers by Matti J Välimäki in
Google Scholar
PubMed
Endocrinology, Department of Public Health, Group Administration, Helsinki University Hospital, University of Eastern Finland, Abdominal Center, University of Helsinki and Helsinki University Hospital, Post Box 340, FI-00290 Helsinki, Finland
Endocrinology, Department of Public Health, Group Administration, Helsinki University Hospital, University of Eastern Finland, Abdominal Center, University of Helsinki and Helsinki University Hospital, Post Box 340, FI-00290 Helsinki, Finland
Search for other papers by Risto P Roine in
Google Scholar
PubMed
Search for other papers by Camilla Schalin-Jäntti in
Google Scholar
PubMed
) . However, symptoms of mild PHPT are difficult to evaluate and so far, no single good predictor of impaired health-related quality of life (HRQoL) in PHPT has been recognized. The value of symptoms as prognostic factors regarding who benefits from surgery
Search for other papers by L M Mongioì in
Google Scholar
PubMed
Search for other papers by R A Condorelli in
Google Scholar
PubMed
Search for other papers by S La Vignera in
Google Scholar
PubMed
Search for other papers by A E Calogero in
Google Scholar
PubMed
with primary or central AI. Another aim was to evaluate health-related quality of life of these subjects, assessed by self-administered questionnaire. Subjects and methods Since the prescription of dual-release hydrocortisone has been approved
Search for other papers by Caroline Nguyen in
Google Scholar
PubMed
Search for other papers by Elisabeth Celestin in
Google Scholar
PubMed
Search for other papers by Delphine Chambolle in
Google Scholar
PubMed
Paris Saclay University, AP-HP, DMU SEA, Endocrinology and Diabetes for Children, Le Kremlin Bicêtre, France
Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Le Kremlin Bicêtre, France
Filière OSCAR and Platform of Expertise for Rare Diseases Paris-Saclay, Bicêtre Paris-Saclay Hospital, INSERM-U1185, Le Kremlin Bicêtre, France
Search for other papers by Agnès Linglart in
Google Scholar
PubMed
APHP-Center for Rare Diseases of Calcium and Phosphate Metabolism, Paris, France
Hôpital Bretonneau, Service de Médecine Bucco-Dentaire, GH Nord Université de Paris, Paris, France
Université de Paris, Inserm U1163, Institute Imagine, Paris, France
Search for other papers by Martin Biosse Duplan in
Google Scholar
PubMed
APHP-Center for Rare Diseases of Calcium and Phosphate Metabolism, Paris, France
Hôpital Bretonneau, Service de Médecine Bucco-Dentaire, GH Nord Université de Paris, Paris, France
Université de Paris, URP2496, Paris, France
Search for other papers by Catherine Chaussain in
Google Scholar
PubMed
Université de Paris Laboratoire ECEVE INSERM, UMR1123, Hôpital Robert Debré, Paris, France
Centre de Reference, Maladies Orales et Dentaires Rares, Hôpital Rothschild, APHP, Paris, France
Filière de Santé Maladies Rares TETECOU, Malformations Rares de la tête, du cou et des dents, Hôpital Necker, Paris, France
Search for other papers by Lisa Friedlander in
Google Scholar
PubMed
XLH, these abnormalities are not secondary effects of the condition but a direct consequence of XLH on the tooth structure. The objective of this study was to evaluate qualitatively the oral care pathways and oral health-related quality of life
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Georgios Kontogeorgos in
Google Scholar
PubMed
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Zoi Mamasoula in
Google Scholar
PubMed
Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Emily Krantz in
Google Scholar
PubMed
Section for Endocrinology, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Penelope Trimpou in
Google Scholar
PubMed
Section for Endocrinology, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Kerstin Landin-Wilhelmsen in
Google Scholar
PubMed
Endocrine Out-Patient Clinic, Carlanderska Hospital, Gothenburg, Sweden
Search for other papers by Christine M Laine in
Google Scholar
PubMed
calcifications in the body, for example in the kidneys, in the basal ganglia of the brain, and in the lenses of the eyes. Patients may also experience various physical and neurocognitive symptoms leading to impaired health-related quality of life (HRQoL) ( 1 , 2
Search for other papers by S Westra in
Google Scholar
PubMed
Search for other papers by Y H M Krul-Poel in
Google Scholar
PubMed
Search for other papers by H J van Wijland in
Google Scholar
PubMed
Search for other papers by M M ter Wee in
Google Scholar
PubMed
Search for other papers by F Stam in
Google Scholar
PubMed
Search for other papers by P Lips in
Google Scholar
PubMed
Search for other papers by F Pouwer in
Google Scholar
PubMed
Search for other papers by S Simsek in
Google Scholar
PubMed
observational studies demonstrated an association between low vitamin D status and a reduced health-related quality of life (HRQOL), fatigue and depressive symptoms ( 8 , 9 , 10 , 11 , 12 , 13 , 14 ). Two recent meta-analyses ( 15 , 16 ) based on the
Search for other papers by Khaled Kabarra in
Google Scholar
PubMed
Search for other papers by Pegah Golabi in
Google Scholar
PubMed
Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA
Inova Medicine, Inova Health System, Falls Church, Virginia, USA
Search for other papers by Zobair M Younossi in
Google Scholar
PubMed
health-related quality of life (HRQoL) burden ( 40 ). It is widely known that patients with CLD suffer from significant impairment of HRQoL as compared to the general population ( 41 ). Fatigue, by far, is the most common symptom reported by patients with
UPMC Univ, Paris, France
Search for other papers by Anne Bachelot in
Google Scholar
PubMed
Search for other papers by Magaly Vialon in
Google Scholar
PubMed
Search for other papers by Amandine Baptiste in
Google Scholar
PubMed
Search for other papers by Isabelle Tejedor in
Google Scholar
PubMed
Search for other papers by Caroline Elie in
Google Scholar
PubMed
Université Paris Descartes, Paris, France
Search for other papers by Michel Polak in
Google Scholar
PubMed
UPMC Univ, Paris, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
Search for other papers by the CRMERC study group in
Google Scholar
PubMed
lost to follow-up ( 12 ). Health-related quality of life (QoL) in adult patients with CAH has been variously reported ( 13 , 14 , 15 ). The reason for this heterogeneity in QoL reporting for CAH adults is debated but could relate to variables
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Search for other papers by Magda Lambaa Altinok in
Google Scholar
PubMed
Search for other papers by Pernille Ravn in
Google Scholar
PubMed
Search for other papers by Kurt Bjerregaard Stage in
Google Scholar
PubMed
Search for other papers by Kurt Højlund in
Google Scholar
PubMed
Search for other papers by Marianne Andersen in
Google Scholar
PubMed
, (2) total and/or free testosterone above upper reference limit and/or hirsutism (Ferriman–Gallwey score (FG-score) ≥8) and (3) polycystic ovaries. Secondary etiologies were excluded as previously described ( 16 ). Health-related quality of life (HRQol